Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntuitive Inv Regulatory News (IIG)

Share Price Information for Intuitive Inv (IIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 122.50
Bid: 120.00
Ask: 125.00
Change: 0.00 (0.00%)
Spread: 5.00 (4.167%)
Open: 122.50
High: 122.50
Low: 122.50
Prev. Close: 122.50
IIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Reorganisation and Deferred Consideration

24 May 2023 07:00

RNS Number : 4034A
Intuitive Investments Group plc
24 May 2023
 

24 May 2023

 

Intuitive Investments Group plc

 

Reorganisation and Deferred Consideration

 

Reorganisation of investment and reduction in deferred consideration

 

Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, announces the proposed reorganisation of Touchless Innovation Limited ("Touchless Innovation") and Touch-Less Hygiene UK Limited ("Touch-Less Hygiene") (together the "Touchless Group") and the reduction in the deferred consideration payable to the vendors of the business and assets of Sanoserv International Franchising Limited.

 

Reorganisation of Touchless Innovation Limited and Touch-Less Hygiene UK Limited

 

The Board of Touchless Innovation, with the agreement of the Board of IIG, has decided to move Touch-Less Hygiene from being a wholly owned subsidiary of Touchless Innovation to beinga wholly owned subsidiary of IIG. Touchless Innovation and Touch-Less Hygiene have different business models. Touchless Innovation is an international franchising business, with master franchisees in 11 countries. Touch-Less Hygiene is a UK market-leading provider of specialist disinfection and decontamination services, with 25 regional sites in the UK and customers that include blue-chip life sciences companies, essential infrastructure firms and the NHS. Given the distinct business models, the board of Touchless Innovation believes that separating and having distinct management teams, will improve both the opportunity for growth and the potential to attract third party funding.

 

Reduction in Deferred Consideration

 

As announced on 25 February 2022, Touchless Innovationacquired the business and assets of Sanoserv International Franchising Limited. The consideration payable by Touchless Innovation to the vendors included £900,000 of deferred consideration payable six months from completion (on 25 August 2022). In substitution for the £900,000 the Boards of IIG and Touchless Innovation have agreed to issue the vendors 2,000,000 new ordinary shares of 1 penny each in IIG ("Consideration Shares"), as well as allowing the vendors the master franchise for Malta for nine years. The minimum royalty amount under the master franchise agreement is $5,400 per annum. In addition, the vendors no longer have the right to appoint a director to the Board of Touchless Innovation, the current cost of which is £25,000 per annum.

 

Admission to trading

 

Application has been made to the London Stock Exchange plc for the admission of the Consideration Shares to trading on AIM, which is expected to take effect at 8.00 a.m. on or around 30 May 2023 ("Admission"). The Consideration Shares will rank equally with the existing ordinary shares of 1 penny each in the share capital of the Company ("Ordinary Shares").

 

Following Admission, the Company's issued share capital will consist of 74,064,551 Ordinary Shares. Since the Company currently holds no shares in treasury, the total number of voting rights in the Company will be 74,064,551. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ('MAR') which has been incorporated into UK law by the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via Regulatory Information Service ('RIS'), this inside information is now considered to be in the public domain.

For further information, please contact:

Intuitive Investments Group plc

+44 (0) 20 3657 0050

Julian Baines, Chairman

Robert Naylor, CEO

Via Turner Pope Investments (TPI) Ltd

 

SP Angel Corporate Finance LLP - Nominated Adviser

+44 (0) 20 3470 0470

Jeff Keating / David Hignell / Kasia Brzozowska

 

Turner Pope Investments (TPI) Ltd - Broker

+44 (0) 20 3657 0050

Andrew Thacker / James Pope

 

 About Intuitive Investments Group plc

Intuitive Investments Group plc is an investment company seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman of the Investment Committee, David Evans, to seek to generate capital growth over the long term for shareholders.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUORNROAUVUAR
Date   Source Headline
30th Dec 202110:58 amRNSResult of AGM
20th Dec 20217:00 amRNSChange of Registered Office
6th Dec 20217:00 amRNSFinal Results and Notice of AGM
29th Nov 20217:00 amRNSChange of Adviser
5th Nov 202110:12 amRNSHolding(s) in Company
28th Oct 20211:38 pmRNSNotice of Results
15th Oct 20218:01 amRNSLight Science Technologies Holdings - Floatation
12th Oct 20219:48 amRNSLight Science Technologies - Intention To Float
20th Sep 20218:04 amRNSLight Science Technologies Holdings - update
15th Sep 20217:00 amRNSInvestment in Momentum Bioscience Limited
20th Aug 20213:40 pmRNSDirector Dealing
29th Jun 202110:56 amRNSInvestment in Midatech Pharma PLC
2nd Jun 20217:00 amRNSInterim report
28th May 20212:18 pmRNSInvestment in Trellus Health plc
4th May 20217:00 amRNSInvestment in The Electrospinning Company Limited
9th Apr 202111:01 amRNSIssue of Shares and Total Voting Rights
1st Apr 20217:00 amRNSInvestment in Axol Bioscience Ltd
31st Mar 20214:18 pmRNSInvestment in Altair
31st Mar 202112:00 pmRNSInvestment in CardiNor AS
17th Mar 20217:00 amRNSInvestment in Polarean Imaging plc
16th Mar 20217:00 amRNSInvestment in Micrima Limited
1st Mar 20217:00 amRNSInvestment in Shield Therapeutics plc
22nd Feb 20217:00 amRNSInvestment in Yourgene Health plc
12th Feb 202111:41 amRNSProposed Investment in Kromek Pharma plc
8th Feb 202111:08 amRNSHolding(s) in Company
3rd Feb 20217:00 amRNSProposed Investment in Evgen Pharma plc
29th Jan 20217:00 amRNSPortfolio company BioQ Pharma receives CE mark
25th Jan 20217:00 amRNSProposed Investment in Microsaic Systems plc
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:35 pmRNSPrice Monitoring Extension
21st Jan 20217:00 amRNSInvestment in BioQ Pharma
11th Jan 20217:00 amRNSPre-IPO Investment in Light Science Technologies
14th Dec 20207:00 amRNSAIM Admission & First Day of Dealings
17th Jul 200610:58 amPRNDirector/PDMR Shareholding
30th Jun 200610:19 amPRNIssue of Equity
20th Jun 20063:08 pmPRNDirector/PDMR Shareholding
2nd Jun 200612:20 pmPRNCorrection : Holding(s) in Company
2nd Jun 200612:05 pmPRNHolding(s) in Company
16th May 200610:35 amPRNDirector/PDMR Shareholding
8th May 20062:30 pmPRNAdditional Listing
27th Apr 20061:07 pmPRNDirectorate Change
13th Apr 20069:46 amPRNDirector/PDMR Shareholding
23rd Mar 20064:53 pmPRNAdditional Listing
13th Mar 200610:41 amPRNDirector/PDMR Shareholding
8th Mar 20063:42 pmPRNNotice of Results
22nd Feb 20064:45 pmPRNDirector/PDMR Shareholding
18th Jan 20065:07 pmPRNDirector/PDMR Shareholding
3rd Jan 20068:30 amPRNTrading Statement
21st Dec 20052:54 pmPRNAdditional Listing
20th Dec 200512:16 pmPRNDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.